Cerivastatin, pitavastatin, simvastatin, and fluvastatin also increased the expression of the KRAS gene, the most frequently mutated gene in pancreatic cancer, and frequently mutated in cancer in general. Here, KRAS is linked to familial pancreatic carcinoma.